p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors

Clinical Cancer Research

Volumn 9, Issue 11, 2003, Pages 4132-4138

  Perrone, Federica ^a   Tabano, Silvia ^a   Colombo, Federica ^a   Dagrada, Gianpaolo ^a   Birindelli, Sarah ^d   Gronchi, Alessandro ^c   Colecchia, Maurizio ^a   Pierotti, Marco A ^b   Pilotti, Silvana ^a,e  

^a U of Exp Molecular Pathology   (Italy)

^b International Center for Pesticides ^*  (Italy)

^c Melanoma and Sarcoma Unit   (Italy)

^d Intl Centre for Pesticide Safety   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PRIMER DNA; PROTEIN P14ARF; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CHILD; CHROMOSOME 9P; CHROMOSOME DELETION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; METHYLATION; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; P14 ARF GENE; P15 INK4B GENE; P16 INK4A GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE; AGED; DRUG ANTAGONISM; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PERIPHERAL NERVE TUMOR;

ADULT; AGED; BASE SEQUENCE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 3843053704     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ducataman, B. S., Scheithauer, B. W., Piepgras, D. G., Reiman, H. M., and Ilstrup, D. M. Malignant peripheral nerve sheath tumors. Cancer (Phila.), 57: 2006-2021, 1986.
2. Birindelli, S., Perrone, F., Oggionni, M., Lavarino, C., Pasini, B., Vergani, B., Ranzani, G. N., Pierotti, M. A., and Pilotti, S. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors (MPNSTs). Lab. Investig., 81: 833-844, 2001.
3. Fletcher, C. D. M., Dal Cin, P., de Wever, I., Mandahl, N., Mertens, F., Mitelman, F., Rosai, J., Rydholm, A., Sciot, R., Tallini, G., van den Berghe, H., Vanni, R., and Willén, H. Correlation between clinicopathological features and karyotype in spindle cell sarcomas. Am. J. Pathol., 154: 1841-1847, 1999.
4. Koga, T., Iwasaki, H., Ishiguro, M., Matsuzaki, A., and Kikuchi, M. Frequent genomic imbalances in chromosome 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis. J. Pathol., 197: 98-107, 2002.
5. Plaat, B. E. C., Molenaar, W. M., Mastik, M. F., Hoekstra, H. J., te Meerman, G. J., and van der Berg, E. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas. Int. J. Cancer, 83: 171-178, 1999.
6. Perry, A., Kunz, S. N., Fuller, C. E., Banerjee, R., Marley, E. F., Liapis, H., Watson, M. A., and Gutmann, D. H. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. J. Neuropathol. Exp. Neurol., 61: 702-709, 2002.
7. Berner, J. M., Sorlie, T., Mertens, F., Henriksen, J., Sæter, G., Mandahl, N., Brogger, A., Myklebost, O., and Lothe, R. A. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway. Genes Chromosome Cancer, 26: 151-160, 1999.
8. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frame of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83: 993-1000, 1995.
9. Nielsen, G. P., Stemmer-Rachamimov, A. O., Ino, Y., Moller, M. B., Rosenberg, A. E., and Louis, D. N. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am. J. Pathol., 155: 1879-1884, 1999.
10. Kourea, H. P., Orlow, I., Scheithauer, B. W. Cordon-Cardo, C., and Woodruff, J. M. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am. J. Pathol., 155: 1855-1860, 1999.
11. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 16: 704-707, 1993.
12. INK4b is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
13. Sher, C. J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res., 60: 3689-3695, 2000.
14. Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., and Sherr, C., J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA, 95: 8292-8297, 1998.
15. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., and Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol., 1: 20-26, 1999.
16. ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA, 96: 6937-6941, 1999.
17. National Institute of Health. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch. Neurol., 45: 575-578, 1998.
18. Tamborini, E., Agus, V., Perrone, F., Papini, D., Romano, R., Pasini, B., Gronchi, A., Colecchia, M. Rosai, J., Pierotti, M. A., and Pilotti, S. Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases. Lab. Investig., 82: 609-618, 2002.
19. Lawn, R. M., Efstratiadis, A., O'Connell, C., and Maniatis, T. The nucleotide sequence of the Human β-globin gene. Cell, 21: 647-651, 1980.
20. Herman, J. G., Graff, J. R., Myohanen, S., Barry, Nelkin, D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
21. Gu, K., Mes-Masson, A. M., Gauthier, J., and Saad, F. Analysis of the p16 tumor suppressor gene in early-stage prostate cancer. Mol. Carcinog., 21: 164-170, 1998.
22. Sauroja, I., Smeds, J., Vlaykova, T., Kumar, R., Talve, L., Hahka-Kemppinen, M., Punnonen, K., Jansèn, C. T., Hemminki, K., and Pyrhönen, S. Analysis of G1/S checkpoint regulators in metastatic melanoma. Genes Chromosomes Cancer, 28: 404-414, 2000.
23. Lòpez-Guerrero, J. A., Pellin, A., Noguera, R., Carda, C., and Llombart-Bosch, A. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab. Investig., 81: 803-814, 2001.